HempNewsBreaks

MondayJun 26, 2017 9:48 am

HempNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends University of Guelph Research Agreement through 2018

ABcann Global Corporation (TSXV: ABCN) this morning announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph in Ontario, Canada. The agreement, which is focused on controlled environment production of medicinal cannabis, now extends to December 31, 2018, and offers an option to extend further if mutually agreed upon. “ABcann has pursued a unique approach to controlled environment production of cannabis designed to standardize the production and quality of medical compounds,” Dr. Michael Dixon, director of the Controlled Environment Systems Research Facility at the…

Continue Reading

ThursdayJun 22, 2017 1:45 pm

HempNewsBreaks – Positive Media Attention Recognizes InMed Pharmaceuticals’ (IMLFF) Operational Developments, Leadership Team

Ongoing media coverage continues to recognize and highlight the achievements of InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a preclinical biopharmaceutical company focused on developing therapies through research and development into the pharmacology of cannabinoids and drug delivery systems. The company was featured as a “Cannabis Runner” by Insider Financial earlier this year, and Forbes also more recently released an article calling InMed “more than just another cannabis drug company.” “Although the company’s pipeline is expected to generate a significant amount of attention in 2018, InMed Pharmaceuticals’ manufacturing system and database are catching the eye of investors and biotech companies. THC and…

Continue Reading

WednesdayJun 21, 2017 3:00 pm

HempNewsBreaks – Grow Condos, Inc. (GRWC) Provides Positive Update on ‘Smoke on the Water’ at Lake Selmac

Grow Condos (OTCQB: GRWC) this morning provided an update on "Smoke on the Water" at Lake Selmac, the company’s resort designed to cater to and capitalize on the country's persistently increasing level of recreational marijuana acceptance. The company reports that the park is undergoing a series of alterations, including culturally diverse upgrades and added value services for patrons of the resort. Among the highlights of the park’s changing atmosphere are the delivery of its tee-pees for its Native American section, which also features yoga and other spiritually enhancing activities. "Smoke on the Water" has launched its own roll up development…

Continue Reading

TuesdayJun 20, 2017 9:29 am

HempNewsBreaks – SinglePoint, Inc. (SING) Secures Funding to Drive Development of Bitcoin Payment Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has successfully closed a $1 million company-friendly convertible promissory note with an institutional investor. Per the update, the company intends to use this funding to execute on its previously announced bitcoin payments solution, which it is developing in partnership with First BitCoin Capital (OTC: BITCF). “This is great timing for SinglePoint. We have many acquisitions deals in the pipeline, and access to this capital will exponentially increase the chances of getting these done,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “In addition, we have many…

Continue Reading

ThursdayJun 15, 2017 3:52 pm

HempNewsBreaks – MYM Nutraceuticals, Inc. (MYMMF) Appoints New Executive Chairman; Details Insider Share Purchases

MYM Nutraceuticals (CSE: MYM) (OTC: MYMMF) earlier this month appointed Erick Factor to the company’s board of directors and as executive chairman. As the founder of Vancouver-based “Westcoast Medicann” dispensary, Factor has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and he has provided medical marijuana to thousands of patients over the past two decades. Additionally, the company released a list of company insiders who bought shares in the last private placement at $0.18; total proceeds from insider share purchases totaled $343,137.96. To view the full press release, visit: http://nnw.fm/e8PuU About MYM MYM Nutraceuticals Inc. (CSE:MYM)…

Continue Reading

ThursdayJun 15, 2017 12:15 pm

HempNewsBreaks – SinglePoint’s (SING) Bitcoin Solution Could Make Marijuana Industry’s Banking Problems a Thing of the Past

Marijuana has now been legalized in some form in 29 states and in the District of Columbia, yet marijuana dispensaries and other cannabis-related businesses lack access to banking options, forcing them to conduct cash only transactions. SinglePoint, Inc. (OTC: SING) may at last have found the answer for these currently “unbankable” businesses by developing a bitcoin payment solution that would enable cannabis users to purchase marijuana products using debit or credit cards. “The company’s SingleSeed subsidiary is already engaged in offering mobile marketing and payment solutions to businesses in the marijuana industry, including cashless ATM, Pay-by-Text™ and text message marketing.…

Continue Reading

ThursdayJun 15, 2017 8:51 am

HempNewsBreaks – Player’s Network, Inc. (PNTV) Bolsters Leadership Team through Addition of Nevada Assistant Controller Geoffrey Lawrence as CFO, CCO

Player’s Network, Inc. (OTCQB: PNTV) this morning announced its appointment of Nevada Assistant Controller Geoffrey Lawrence as the company’s chief financial officer and chief compliance officer, effective July 1, 2017. “Geoffrey is a senior-level operator who will help us fulfill our commitment to our shareholders and the investment community insofar as our goals of increased transparency and stronger corporate governance,” Mark Bradley, CEO of PNTV, stated in the news release. “As PNTV continues to grow its assets, it is necessary that we assemble a strong first-class management team, and Geoffrey is a perfect fit, bringing to the table the necessary…

Continue Reading

WednesdayJun 14, 2017 10:55 am

HempNewsBreaks – Research Report Highlights Hefty Market Potential for ChineseInvestors.com, Inc. (CIIX)

ChineseInvestors.com, Inc. (OTCQB: CIIX), which recently took part in SeeThruEquity’s 6th Annual Microcap Investor Conference in early June, offers educational consulting services for Chinese investors and is also pursuing opportunities in the cannabis market.  SeeThruEquity recently increased the price target on CIIX to $3.75 from $2.05, and predicted that revenues from the company’s hemp business could reach 8-digit sales by 2020. “The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in…

Continue Reading

WednesdayJun 14, 2017 9:25 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 9:00 am

HempNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading